Introduction
Studying the flow dynamics of the blood cells in the retinal and choroidal circulation is imperative to understanding the pathogenesis of potentially vision-threatening ocular diseases and other ocular inflammatory conditions. However, the conventional angiography techniques, which involve the binding of fluorescent dyes to plasma proteins, do not provide any information regarding the dynamics of the erythrocytes or leukocytes 1 .
The erythrocyte retinal flow dynamics are important for studying metabolically efficient circulation in the retina, and the leukocyte flow dynamics, for understanding the cell migration, recognition, adhesion and destruction in various inflammatory conditions 2 . There are several fluorescent molecules used in the identification and characterization of various cell types 3 . The hemodynamics of the blood cells can be measured by staining them with the appropriate fluorescent dyes and applying the proper imaging techniques 4 .
The presence of inflammatory responses in intraocular diseases like age-related macular degeneration (AMD) and diabetic retinopathy (DR) involve the accumulation of lymphocytes in the diseased area 5, 6 . Tracking the immune cells in the tissues can help understand the complex events involved in the mechanism of disease pathogenesis. Radioactive isotopes like 51 Cr and 125 I were used as cell tracers in early studies. These dyes are toxic and affect the cell viability. Although the radioactive markers 3 H and 14 C are less toxic to the cells, due to their lower emission energies, it is difficult to detect their signals in the system 7, 8 . A number of fluorochrome dyes were introduced to overcome the potential problems associated with radioactive markers and track lymphocyte migration in vitro using fluorescent microscopy and flow cytometry 9, 10 . Hoechst 33342 and thiazole orange are DNA binding fluorescent dyes, which are used to track lymphocytes in vivo. Hoechst 33342 binds to ATrich regions in the DNA, is membrane permeable, retains fluorescent signals for 2 -4 days and is resistant to quenching 9, 10 . The disadvantages of Hoechst 33342 and thiazole orange are the inhibition of lymphocyte proliferation 11 and the short half-life, respectively 9 .
Calcein-AM, fluorescein diacetate (FDA), 2′,7′-bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein, acetoxymethyl ester (BCECF-AM), 5-(and-6)carboxyfluorescein diacetate (CFDA), and 5-(and-6)-carboxyfluorescein diacetate acetoxymethyl ester (CFDA-AM) are the cytoplasmic fluorescent dyes used for lymphocyte migration studies. However, FDA, CFDA and CFDA-AM have lower retention in the cells 9 . BCECF-AM reduces the proliferative response and influences the chemotaxis and superoxide production 9, 12 . Calcein-AM is a fluorescent dye and useful for short-term in vivo lymphocyte migration studies. It emits strong fluorescent signals, does not interfere with most of the cellular functions and retains fluorescent signals for up to 3 days 12, 13 a stronger affinity with B lymphocytes than T lymphocytes 14, 15 . The CFDA-SE labeled lymphocytes can be tracked in vivo for more than 8 weeks and up to 8 cell divisions 9, 16 . C18 DiI (1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate), DiO (3,3'-dioctadecyloxacarbocyanine perchlorate), Paul Karl Horan (PKH)2, PKH3, and PKH26 are membrane-inserting fluorescent lipophilic carbocyanine dyes used to label leukocytes and erythrocytes. C18 Dil and DiO exhibit higher signals when incorporated into the cell membrane and are relatively non-toxic 12, 17 . PKH2, PKH3 and PKH26 labeled cells exhibit a good retention of the fluorescent signals with less toxicity 18, 19, 20, 21, 22 . However, PKH2 down regulates the CD62L expression and reduces the lymphocyte viability 23 .
Most of the above-mentioned studies have been performed for tracking the lymphocyte migration and proliferation in the lymphatics and studying the labeled erythrocytes in the non-ocular circulation. There are very few studies applying the labeling techniques to study the blood cells in the ocular circulation. Application of scanning laser ophthalmoscopy (SLO) has a great advantage in studying the labeled cells in the retinal and choroidal circulation in vivo by fundus angiography 24 . There are several fluorescent dyes, such as ICG, acridine orange, FITC, sodium fluorescein, and CFDA that are used to study the leukocytes in the retinal circulation by SLO 25, 26, 27, 28, 29, 30, 31, 32, 33, 34 . The phototoxicity and carcinogenicity of acridine orange 26, 27 , the interference of FITC with the cellular activity, and the requirement of an intravascular contrast agent for the resolution of the retinal and choroidal blood vessels limits their application in in vivo animal experiments 29 . Sodium fluorescein and ICG are non-toxic, approved by the Food and Drug Administration, and safe for testing on humans 32, 35 . Most of the flow dynamic studies are related to the labeling of the leukocytes or erythrocytes and its visualization in the retinal and choroidal blood vessels 36, 37, 38, 39 . Here, we describe a standardized protocol of ICG labeling of the erythrocytes, sodium fluorescein labeling of the leukocytes, and tracking the visualized labeled cells in the mouse retinal circulation using SLO.
Protocol
The animal protocols used in this study were approved by the Institutional Animal Care and Use Committee of SingHealth, Singapore and are in accordance to the guidelines of the Association for Research in Vision and Ophthalmology (ARVO) Statement for the Use of Animals in Ophthalmic and Vision Research. NOTE: Occasionally, the circles marking the previous points in the trajectory interfere with the ability to view the current location. If this occurs, proceed to step 2.3.5.3.1.
1. Change the display option for the trajectory by clicking on "Displaying" in the menu and selecting the option "display only track points at current time". To see all the trajectories, de-select this option.
4. Continue clicking until the trajectory of the first cell is seen. Then save the track by clicking "Save". 6 . Track the second cell. 1. In the menu, click "Add" to start a new track. Repeat steps 2.3.5.1 -2.3.5.4 for tracking the new cell. Click on "Save" to save the second track. 2. Continue these steps for all trackable cells observed. After tracking the cells, click on "Measure" and "OK" in the menu tab to get the results. NOTE: A results window opens up automatically, which can be saved and opened in a spreadsheet for further analysis.
Representative Results
Erythrocytes labeled with 1.5% ICG were visualized in the retinal circulation of C57BL/6J mice (wild type). Both 1% and 5% hematocrit of 1.5% ICG labeled erythrocytes were distinguishable in the retinal circulation. However, the individual labeled cells were more clearly visualized with 1% hematocrit of 1.5% ICG labeled erythrocytes (Figure 1) . In 5% hematocrit, due to the large number of labeled cells in the retinal vessels, it was not possible to mark the individual cell. Some erythrostasis was observed in the peripapillary region under both conditions, but it was more prominent in the 5% hematocrit of labeled erythrocytes (Figure 2) .
Leukocytes were successfully labeled with 1% sodium fluorescein following the above protocol and were visualized as green labeled cells using the fluorescent microscopy (Figure 3) . Small clumps of cells (4 -5 cells together) were also observed in labeled samples. When the cells were injected into the mouse circulation, labeled leukocytes were visualized in the retinal circulation (Figure 4) . After the labeling, both the erythrocytes and leukocytes were immediately injected into the mice and visualized at 30 and 60 min time intervals. Fluorescently labeled cells were observed immediately after the injection, but the fluorescence intensities gradually decreased at 30 and 60 min time intervals. We also used the leukocyte staining protocol (1% sodium fluorescein) on the erythrocytes and observed no labeling of the erythrocytes. Using the Mtrack J plugin on the Image J public domain software, the cells were tracked in the retinal circulation (Figure 5 ). , they share the limitation of the inability to study the flow dynamics of individual cell types. The nutrients and oxygen supply to the retinal and choroidal tissues, as well as the migration of immune cells in ocular inflammatory diseases and their role in the disease pathogenesis, can be studied by investigating the flow dynamics of erythrocytes and leukocytes in retinal and choroidal circulation, respectively. Labeling techniques coupled with imaging methods will help to track the labeled cells in the circulation and to study the flow dynamics of the labeled cells. Several fluorescent dyes were successfully applied to label the leukocytes and erythrocytes for investigation of their flow dynamics in the circulation 3, 17, 18, 19 .
Here, we report the application of Food and Drug Administration approved non-toxic fluorescent dyes, indocyanine green and sodium fluorescein, for the labeling and visualization of the erythrocytes and leukocytes in the retinal circulation, respectively. Although sodium fluorescein is the most commonly used dye for tracking the leukocytes 31, 32, 33, 34 , the advantage of simultaneously labeling erythrocytes and leukocytes with ICG and sodium fluorescein, respectively is efficient visualization of labeled cells concurrently in the animal's eye by changing the filters in the SLO. SLO is a non-invasive method of retinal imaging that is extensively used in the study of pathological changes in various retinal diseases in humans and animals. It can also help in comparing retinal changes in response to a given treatment 46 .
To achieve quality images in the SLO, the pupils need to be fully dilated and the contact lens must be used with ophthalmic gel to maintain a moist cornea and prevent cataract formation. The position of the eyes and the optical path of the camera must be straight to achieve quality fundus and angiogram images. The animal should be deeply sedated to minimize movement during the imaging. Although both 1% and 5% hematocrit of 1.5% ICG labeled erythrocytes demonstrated the visualization of fluorescently labeled cells in the retinal circulation, 1% hematocrit was better suited for monitoring the individual cells. Fluorescently labeled cells cannot be visualized if the number of injected leukocytes is too low. Therefore, to achieve better results in monitoring the labeled cells in the retinal circulation, it is recommended to collect leukocytes from at least 4 mice, label with 1% sodium fluorescein, and inject into a single mouse. Although there are some alternative dyes for sodium fluorescein (Calcein, FITC, DIO, FDA and CFDA with absorption/emission maxima similar to or near sodium fluorescein), the dye retention rate and toxicity to ocular tissues must be evaluated 9, 12, 13, 14, 17 .
The limitation of the reported technique is the fading of the fluorescent signal in circulation after 60 min. Therefore, the flow dynamics of the labeled cells must be analyzed within 60 min. Here, to label leukocytes, blood was withdrawn from one mouse, cells were isolated, labeled, injected into another mouse, and visualized by SLO. However, in SLO, only 0 -1 cell per frame was observed in retinal blood vessels. This could be due to insufficient leukocyte cell number and so we recommend to collect blood from at least 3 -4 mice to visualize a higher cell number per frame. The camera speed of 8.8 frames/s was used in the study, but this could be increased to achieve more sequential images and videos of the labeled cells. A decreased blood flow velocity was also reported to be associated with progressive glaucoma 49 . In the aforementioned studies, the authors investigated the whole blood flow velocities in the retinal circulation. Studying the flow velocities of each cell type can provide information about the cellular interactions in different diseases and at different stages of disease and may help in prognosis. Here we report a method to label the erythrocytes and leukocytes with ICG and sodium fluorescein, respectively and their visualization in the retinal circulation; this method can be applied on any disease model for in vivo studies.
Future research can utilize our labeling techniques using SLO to study the variation in flow dynamics of the labeled erythrocytes and leukocytes under different drug treatment conditions at various stages of the disease. Furthermore, our methods can help understand the role of erythrocytes and leukocytes in disease phenotypes.
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